NIH-funded research NIH-funded research

Developing new treatments for respiratory infections using nanoformulations

Official title: Nanoformulations for Respiratory Infections

Funded at James a. Haley VA Medical Center · NIH-10923474 · Data updated 2026-11-12

This study is working on a new nasal treatment to help fight respiratory viruses like COVID-19 and RSV, especially for older adults who are more vulnerable, by using tiny particles to deliver medicine directly to the lungs and boost the immune system.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJames a. Haley VA Medical Center
NIH-funded
Lab location1 site (Tampa, United States)
Project startOctober 1, 2024
Project endSeptember 30, 2028
Funding year2025
NIH project number1I01BX006456-01A1
Project IDNIH-10923474 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are elderly individuals aged 65 and older who are at risk for severe respiratory infections.

Less likely to help

Patients under the age of 65 or those without a history of severe respiratory infections may not benefit from this research.

What this research studies

This research focuses on creating innovative antiviral treatments for respiratory infections, particularly targeting viruses like SARS-CoV-2 and RSV. The approach involves developing a specialized intranasal nanoformulation that utilizes liposomes to deliver therapeutic agents directly to the respiratory system. By incorporating specific compounds that can enhance the immune response and inhibit viral replication, the research aims to provide a more effective treatment option for patients, especially the elderly who are at higher risk. The methodology includes the use of advanced nanotechnology to ensure sustained release of the therapeutic agents.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for severe respiratory infections, potentially reducing hospitalizations and improving survival rates among vulnerable populations.

How similar studies have gone: Previous research has shown promise in using nanotechnology for drug delivery in respiratory infections, indicating potential for success in this novel approach.

Where this research is happening

  • James a. Haley VA Medical Center
    Tampa, United States
    Active

Researchers

  • Principal investigator: Mohapatra, Shyam S — James a. Haley VA Medical Center
  • Study coordinator: Mohapatra, Shyam S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.